Biotechnological Innovations in Vaccine Development: Lessons from the COVID-19 Pandemic
Natalia Ivanova
University of Lyon, France
DOI:https://doi.org/10.5912/jcb2518
Abstract:
The COVID-19 pandemic catalyzed incredible advancements in vaccine biotechnology, disrupting conventional techniques and establishing infectious disease response frameworks. This work assesses the innovations in mRNA vaccine technologies, viral vector platforms, and genomic sequencing that facilitated the rapid creation and distribution of COVID-19 vaccines. The research study based on primary data analysis for determine the research used Smart PLS software for measuring the result related to biotechnological innovations and vaccine development. The pandemic brought to the forefront the importance of collaboration, regulatory flexibility, and scalable production for effective global vaccine dissemination. In addition, it underscored obstacles like supply chain constraints and equitable access to immunization. Overall result found directly link in between biotechnological innovation in vaccine development. Another result found that significant link between them. This research proposes that in the aftermath of the COVID-19 pandemic, investment in biotechnological innovations, proactive responses to pandemics, and vaccine accessibility would serve to strengthen global health security in coming decades.